Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Aril Frydén"'
Autor:
Aril Frydén, I. Uhnoo, Anette Brass, Patrick Behrendt, Ola Weiland, Kristina Cardell, Dorothea Bankwitz, Gunnar Norkrans, A. Eilard, Hans Glaumann, Matti Sällberg, Magnus Hedenstierna, Thomas Pietschmann, Erwin Daniel Brenndörfer, Soo Aleman
Publikováno v:
Alimentary Pharmacology & Therapeutics. 41:532-543
A sustained viral response (SVR) after interferon-based therapy of chronic hepatitis C virus (HCV) infection is regarded to represent a cure. Previous studies have used different markers to clarify whether an SVR truly represents a cure, but no study
Publikováno v:
Acta Neurologica Scandinavica. 61:306-312
Patients with aseptic meningitis (AM) were examined with the active T cell rosette test, which has been claimed to reflect cell-mediated immunocompetence more accurately than determination of total T cells. Higher percentages of active T cells were d
Autor:
P Tobiasson, B Kågedal, U. Foberg, C. Broström, Hans Glaumann, Aril Frydén, Ola Weiland, J. Mårtensson
Publikováno v:
Liver. 7:116-122
In 40 patients with histologically verified chronic hepatitis, (chronic persistent hepatitis, n = 13; chronic active hepatitis without, n = 14; or with cirrhosis, n = 13), of viral and autoimmune origin, serum bile acids (SBA) were measured before an
Autor:
Robert Schvarcz, Ola Weiland, Gunnar Norkrans, Aril Frydén, Hans Glaumann, Olle Reichard, Rune Wejstål
Publikováno v:
Liver. 14:169-174
Forty patients with chronic hepatitis C virus (HCV) infection were treated with 3 MU interferon alfa-2b given subcutaneously for 60 weeks. A biochemical response with normalization of serum alanine aminotransferase (s-ALT) levels was seen in 24 patie
Publikováno v:
Liver. 11:30-38
The histological outcome in liver biopsies following 9 months of interferon alpha-2b treatment was assessed in detail in 19 patients with chronic posttransfusion non-A, non-B hepatitis (PTH-NANB) and compared with 12 untreated PTH-NANB patients. Four
Autor:
Jessica Nyström, Aril Frydén, Matti Sällberg, Kristina Cardell, Thora Björg Björnsdottir, Catharina Hultgren
Publikováno v:
Vaccine. 26:5967-5972
We successfully re-vaccinated hepatitis B virus (HBV) vaccine non-responders using a double dose of the combined hepatitis A virus (HAV) and HBV vaccine. The hope was to improve priming of hepatitis B surface antigen (HBsAg)-specific cell mediated im
Publikováno v:
The Journal of Infectious Diseases. 198:299-304
Hepatitis B virus causes liver disease and up to 2 billion people have been in contact with the virus world wide. It can cause both acute and chronic disease. The routes for transmission are through blood, mother to infant at time of delivery and sex
Autor:
Kristina Cardell, U-B Lymer, Barbro Isaksson, Stefan Franzén, Britt Åkerlind, Aril Frydén, A-S Månsson, Anders Widell
Publikováno v:
Journal of Hospital Infection. 68:322-328
We describe the transmission of hepatitis C virus (HCV) to two patients from a thoracic surgeon who was unaware of his hepatitis C infection. By partial sequencing of the non-structural 5B gene and phylogenetic analysis, the viruses from both patient
Autor:
U Foberg, M. Resjo, L. Jacobsson, UL Mathiesen, Göran Bodemar, Aril Frydén, Lennart Franzén, H Åselius
Publikováno v:
Digestive and Liver Disease. 34:516-522
Aims. To investigate whether hyperechogenicity of liver can reliably be interpreted as liver steatosis and if any concomitant or isolated fibrosis can be disclosed. Patients and methods. A series of 165 patients with no signs or symptoms of liver dis
Autor:
Gunnar Norkrans, Jean Henrik Braconier, Ola Weiland, Olle Reichard, Ingrid Uhnoo, Aril Frydén
Publikováno v:
Karolinska Institutet
A total of 172 Swedish patients treated with interferon-alpha for at least 24 weeks and followed-upor =24 weeks after treatment was stopped were analysed for pre-treatment factors of importance for achieving a virological sustained response (SR). Fur